BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 7910035)

  • 1. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states.
    Stone JR; Marletta MA
    Biochemistry; 1994 May; 33(18):5636-40. PubMed ID: 7910035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme.
    Burstyn JN; Yu AE; Dierks EA; Hawkins BK; Dawson JH
    Biochemistry; 1995 May; 34(17):5896-903. PubMed ID: 7727447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
    Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
    J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ferrous heme of soluble guanylate cyclase: formation of hexacoordinate complexes with carbon monoxide and nitrosomethane.
    Stone JR; Marletta MA
    Biochemistry; 1995 Dec; 34(50):16397-403. PubMed ID: 8845366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide.
    Stone JR; Marletta MA
    Chem Biol; 1998 May; 5(5):255-61. PubMed ID: 9646941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral and ligand-binding properties of an unusual hemoprotein, the ferric form of soluble guanylate cyclase.
    Stone JR; Sands RH; Dunham WR; Marletta MA
    Biochemistry; 1996 Mar; 35(10):3258-62. PubMed ID: 8605161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the heme binding region in soluble guanylate cyclase.
    Zhao Y; Marletta MA
    Biochemistry; 1997 Dec; 36(50):15959-64. PubMed ID: 9398330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of nitric oxide and carbon monoxide to soluble guanylate cyclase as observed with Resonance raman spectroscopy.
    Deinum G; Stone JR; Babcock GT; Marletta MA
    Biochemistry; 1996 Feb; 35(5):1540-7. PubMed ID: 8634285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide.
    Stone JR; Marletta MA
    Biochemistry; 1996 Jan; 35(4):1093-9. PubMed ID: 8573563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme stoichiometry of heterodimeric soluble guanylate cyclase.
    Stone JR; Marletta MA
    Biochemistry; 1995 Nov; 34(45):14668-74. PubMed ID: 7578074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin.
    Brandish PE; Buechler W; Marletta MA
    Biochemistry; 1998 Dec; 37(48):16898-907. PubMed ID: 9836582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resonance raman characterization of the heme domain of soluble guanylate cyclase.
    Schelvis JP; Zhao Y; Marletta MA; Babcock GT
    Biochemistry; 1998 Nov; 37(46):16289-97. PubMed ID: 9819221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms.
    Ignarro LJ; Adams JB; Horwitz PM; Wood KS
    J Biol Chem; 1986 Apr; 261(11):4997-5002. PubMed ID: 2870064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic characterization of the soluble guanylate cyclase-like heme domains from Vibrio cholerae and Thermoanaerobacter tengcongensis.
    Karow DS; Pan D; Tran R; Pellicena P; Presley A; Mathies RA; Marletta MA
    Biochemistry; 2004 Aug; 43(31):10203-11. PubMed ID: 15287748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of soluble guanylate cyclase by ODQ.
    Zhao Y; Brandish PE; Di Valentin M; Schelvis JP; Babcock GT; Marletta MA
    Biochemistry; 2000 Sep; 39(35):10848-54. PubMed ID: 10978171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide.
    Craven PA; DeRubertis FR
    Biochim Biophys Acta; 1983 Jun; 745(3):310-21. PubMed ID: 6134553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: a mechanistic model.
    Sharma VS; Magde D
    Methods; 1999 Dec; 19(4):494-505. PubMed ID: 10581149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung.
    Ignarro LJ; Degnan JN; Baricos WH; Kadowitz PJ; Wolin MS
    Biochim Biophys Acta; 1982 Sep; 718(1):49-59. PubMed ID: 6128034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme.
    Ignarro LJ; Wood KS
    Biochim Biophys Acta; 1987 Apr; 928(2):160-70. PubMed ID: 2882783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of recombinant human soluble guanylate cyclase produced from baculovirus-infected insect cells.
    Emmons TL; Mathis KJ; Shuck ME; Reitz BA; Curran DF; Walker MC; Leone JW; Day JE; Bienkowski MJ; Fischer HD; Tomasselli AG
    Protein Expr Purif; 2009 Jun; 65(2):133-9. PubMed ID: 19189860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.